CNBC’s Jim Cramer delivers his daily Mad Dash.

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are broadening, with ...

Deep oceans contain microbes with yet-to-be-discovered properties that could drive future innovations in biotechnology.

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast ...

Morgan Stanley says U.S. equity-market leadership is beginning to expand beyond the semiconductor and AI infrastructure ...

The artificial intelligence buildout has run headlong into a physical bottleneck: electricity. Data centers are demanding ...

Met a bulin, a Texas-based biotechnology company led by Hua Tu, PhD, is working to develop an ultra-stable insulin formulation that remains viable even at high temperatures. “Insulin instability has ...